Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02513407 · ClinicalTrials.gov registry record · NA

Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities

A NA study of Healthy Subject, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02513407: Active NA study of Healthy Subject, sponsored by City of Hope Medical Center.

NCT02513407 is a NA study of Healthy Subject that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 50 participants, below the 245-participant average among 16 other Healthy Subject trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02513407, a NA study of Healthy Subject, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This randomized pilot research trial studies how well Eat, Move, Live (EML) works in reducing chronic disease risk in medically vulnerable communities. Obesity, unhealthy diet, and physical inactivity are linked to increased cancer risk, especially hormone-related cancer (example, breast cancer). Improving healthy lifestyle practices, namely increasing physical activity and encouraging healthy eating behaviors may reduce the risk of getting cancer and chronic disease.

Primary Outcome

Will convert plasma glucose into binary outcome variables and evaluate the effect on intervention on these outcomes controlled for significant confounders (age, income, and education will be evaluated for confounding in the logistic regression model). Chi-square goodness of fit tests will compare percent reduction in weight between the control and intervention groups. Chi square tests will be used to determine whether participants reduced weight by 3%. Repeated ANCOVA will be used. Outcome varia

Conditions Studied

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Educational Intervention
  • BEHAVIORAL Exercise Intervention
  • BEHAVIORAL Behavioral Dietary Intervention

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-04-06
Est. Completion 2026-08-10
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT02513407 still lists

NCT02513407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 245-participant average among 16 other Healthy Subject trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT02513407 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02513407 about?

NCT02513407 is a clinical study titled "Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities". This randomized pilot research trial studies how well Eat, Move, Live (EML) works in reducing chronic disease risk in medically vulnerable communities. Obesity, unhealthy diet, and physical inactivity are linked to increased cancer risk, especially hormone-related cancer (example, breast cancer). Im...

What is the current status of trial NCT02513407?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2016-04-06. Estimated completion is 2026-08-10.

What conditions does trial NCT02513407 study?

This clinical trial studies the following conditions: Healthy Subject.

What interventions are being tested in trial NCT02513407?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Educational Intervention (OTHER), Exercise Intervention (BEHAVIORAL), Behavioral Dietary Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02513407?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02513407 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02513407's enrollment target sits among peer trials

50 11th of 16 higher than 6 of 16 other Healthy Subject trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02513407, the US trial registry maintained by the National Library of Medicine. NCT02513407 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.